IRIS
MACCARRONE, MAURO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 20.635
EU - Europa 1.730
AS - Asia 811
Continente sconosciuto - Info sul continente non disponibili 11
SA - Sud America 11
OC - Oceania 7
AF - Africa 5
Totale 23.210
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 20.620
SG - Singapore 439
UA - Ucraina 275
DE - Germania 258
CN - Cina 216
IE - Irlanda 216
IT - Italia 168
FR - Francia 146
RU - Federazione Russa 142
SE - Svezia 133
KR - Corea 108
PL - Polonia 104
GB - Regno Unito 95
NL - Olanda 71
FI - Finlandia 66
CZ - Repubblica Ceca 24
EU - Europa 10
KG - Kirghizistan 10
CA - Canada 8
BE - Belgio 7
JP - Giappone 7
AU - Australia 6
IL - Israele 6
BR - Brasile 5
IR - Iran 5
CL - Cile 4
DK - Danimarca 4
DM - Dominica 4
IN - India 4
RS - Serbia 4
VN - Vietnam 4
ZA - Sudafrica 4
CH - Svizzera 3
LT - Lituania 3
MX - Messico 3
ES - Italia 2
NO - Norvegia 2
RO - Romania 2
TW - Taiwan 2
UZ - Uzbekistan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AZ - Azerbaigian 1
BG - Bulgaria 1
CO - Colombia 1
ET - Etiopia 1
GR - Grecia 1
HK - Hong Kong 1
HU - Ungheria 1
IQ - Iraq 1
KW - Kuwait 1
LK - Sri Lanka 1
MK - Macedonia 1
NZ - Nuova Zelanda 1
PE - Perù 1
PT - Portogallo 1
QA - Qatar 1
TH - Thailandia 1
TR - Turchia 1
Totale 23.210
Salva come PNG Salva come JPEG
Città #
Woodbridge 5.906
Wilmington 5.610
Houston 4.885
Fairfield 815
Ann Arbor 548
Chandler 397
Singapore 382
Ashburn 309
Seattle 298
Cambridge 254
Jacksonville 242
Dublin 207
Medford 161
Beijing 115
Kraków 101
Santa Clara 96
Lawrence 76
New York 72
Dearborn 64
Rome 45
Mülheim 37
San Diego 34
Menlo Park 31
Zhengzhou 29
Brno 24
Milan 18
Moscow 18
Redwood City 17
Norwalk 16
San Mateo 16
Saint Petersburg 15
University Park 15
Falls Church 14
Mountain View 14
London 12
Helsinki 11
Kunming 11
Nanjing 10
Palo Alto 10
Bari 9
Los Angeles 9
Nürnberg 8
Verona 8
Brussels 7
Munich 7
Boardman 6
Detroit 6
Hefei 6
Shanghai 6
Berlin 5
Guangzhou 5
Mcallen 5
San Francisco 5
Seoul 5
Chicago 4
Hounslow 4
Jinan 4
Redmond 4
Roseau 4
São Paulo 4
Toronto 4
Clearwater 3
Council Bluffs 3
Del Norte 3
Dong Ket 3
Fremont 3
Garden City 3
Hanover 3
Lappeenranta 3
Montague 3
Nashville 3
Rodigo 3
Royal Oak 3
Salt Lake City 3
Turin 3
Agliana 2
Alderley Edge 2
Ancona 2
Auburn Hills 2
Belgrade 2
Bloemfontein 2
Buffalo 2
Carate Brianza 2
Cesano Maderno 2
Chongqing 2
Dongguan 2
Fars 2
Frankfurt am Main 2
Frederiksberg 2
Fuzhou 2
Giv‘atayim 2
Head of Westport 2
Hebei 2
Islington 2
Kilburn 2
Liverpool 2
Mexico City 2
Nanchang 2
New Bedfont 2
Philadelphia 2
Totale 21.152
Salva come PNG Salva come JPEG
Nome #
Cannabinoids therapeutic use: what is our current understanding following the introduction of THC, THC:CBD oromucosal spray and others? 510
Abnormal mGlu 5 receptor/endocannabinoid coupling in mice lacking FMRP and BC1 RNA 460
Cerebrospinal fluid levels of the endocannabinoid anandamide are reduced in patients with untreated newly diagnosed temporal lobe epilepsy. 441
Downstream effects of endocannabinoid on blood cells: Implications for health and disease 441
Distinct modulation of human myeloid and plasmacytoid dendritic cells by anandamide in multiple sclerosis 433
Chronic cocaine sensitizes striatal GABAergic synapses to the stimulation of cannabinoid CB1 receptors 432
Type-1 cannabinoid receptors colocalize with caveolin-1 in neuronal cells 426
Interaction between interleukin-1β and type-1 cannabinoid receptor is involved in anxiety-like behavior in experimental autoimmune encephalomyelitis 425
The (endo)cannabinoid system in multiple sclerosis and amyotrophic lateral sclerosis 424
High endogenous cannabinoid levels in the cerebrospinal fluid of untreated Parkinson's disease patients 424
Modulation of monocytes by bioactive lipid anandamide in multiple sclerosis involves distinct Toll-like receptors 423
Age-related changes of anandamide metabolism in CB1 cannabinoid receptor knockout mice: correlation with behaviour 419
The (AAT)n repeat of the cannabinoid CB1 receptor gene influences disease progression in relapsing multiple sclerosis. 418
Abnormal sensitivity to cannabinoid receptor stimulation might contribute to altered gamma-aminobutyric acid transmission in the striatum of R6/2 Huntington's disease mice 418
Abnormal sensitivity of cannabinoid CB1 receptors in the striatum of mice with experimental amyotrophic lateral sclerosis 412
Lack of effect of cannabis-based treatment on clinical and laboratory measures in multiple sclerosis 412
TRPV1 channels facilitate glutamate transmission in the striatum 411
The brain cytoplasmic RNA BC1 regulates dopamine D2 receptor-mediated transmission in the striatum 404
Brain-derived neurotrophic factor controls cannabinoid CB1 receptor function in the striatum 403
Subventricular zone neural progenitors protect striatal neurons from glutamatergic excitotoxicity 402
Urinary N-acetyl-beta-D-glucosaminidase concentration in patients with spinal cord injury: relationship with urodynamic parameters 401
Trans-crocetin improves amyloid-β degradation in monocytes from Alzheimer's Disease patients 401
Effects of palmitoylation of Cys(415) in helix 8 of the CB(1) cannabinoid receptor on membrane localization and signalling 400
Cannabinoid CB1 receptors regulate neuronal TNF-α effects in experimental autoimmune encephalomyelitis 394
TRPV1 channels regulate cortical excitability in humans 394
The endocannabinoid system in peripheral lymphocytes as a mirror of neuroinflammatory diseases 393
null 393
Preservation of striatal cannabinoid CB1 receptor function correlates with the antianxiety effects of fatty acid amide hydrolase inhibition 392
Transient receptor potential vanilloid 1 channels modulate the synaptic effects of TNF-α and of IL-1β in experimental autoimmune encephalomyelitis 387
Dopamine-dependent CB1 receptor dysfunction at corticostriatal synapses in homozygous PINK1 knockout mice 385
Comment on "Cannabinoid receptor and N-acyl phosphatidylethanolamine phospholipase D--evidence for altered expression in multiple sclerosis" 383
Endocannabinoids limit metabotropic glutamate 5 receptor-mediated synaptic inhibition of striatal principal neurons 383
Structure-to-function relationship of mini-lipoxygenase, a 60-kDa fragment of soybean lipoxygenase-1 with lower stability but higher enzymatic activity 381
Experimental parkinsonism alters endocannabinoid degradation: implications for striatal glutamatergic transmission 379
Interleukin-1β Causes Anxiety by Interacting with the Endocannabinoid System 379
The endocannabinoid pathway in Huntington's disease: a comparison with other neurodegenerative diseases 378
HIV-1 coat glycoprotein gp120 induces apoptosis in rat brain neocortex by deranging the arachidonate cascade in favor of prostanoids 373
A critical interaction between dopamine D2 receptors and endocannabinoids mediates the effects of cocaine on striatal gabaergic Transmission 371
Pre- and postsynaptic type-1 cannabinoid receptors control the alterations of glutamate transmission in experimental autoimmune encephalomyelitis 370
The endocannabinoid system in targeting inflammatory neurodegenerative diseases 369
Type-1 (CB1) cannabinoid receptor promotes neuronal differentiation and maturation of neural stem cells . 365
GADD153 and 12-lipoxygenase mediate fenretinide-induced apoptosis of neuroblastoma 362
Stimulation of autophagy by rapamycin protects neurons from remote degeneration after acute focal brain damage 360
Levodopa treatment reverses endocannabinoid system abnormalities in experimental parkinsonism 359
The endocannabinoid system and its therapeutic exploitation in multiple sclerosis: Clues for other neuroinflammatory diseases 356
Altered anandamide degradation in attention-deficit/hyperactivity disorder 354
Exploitation of the HIV-1 coat glycoprotein, gp120, in neurodegenerative studies in vivo 348
Functional characterization of putative cholesterol binding sequence (CRAC) in human type-1 cannabinoid receptor 343
In vitro and in vivo models of Huntington's disease show alterations in the endocannabinoid system 340
Cannabinoid receptor signaling in neurodegenerative diseases: a potential role for membrane fluidity disturbance 338
Association between a genetic variant of type-1 cannabinoid receptor and inflammatory neurodegeneration in multiple sclerosis 337
Lipid rafts regulate 2-arachidonoylglycerol metabolism and physiological activity in the striatum 335
TRPV1 channels regulate cortical excitability in humans 263
Potential for diagnosis versus therapy monitoring of attention deficit hyperactivity disorder: a new epigenetic biomarker interacting with both genotype and auto-immunity 253
Early alteration of distribution and activity of hippocampal type-1 cannabinoid receptor in Alzheimer's disease-like mice overexpressing the human mutant amyloid precursor protein 208
CSF levels of the endocannabinoid anandamide are reduced in patients with untreated narcolepsy type 1: a pilot study 189
From Traumatic Childhood to Cocaine Abuse: The Critical Function of the Immune System 175
Essential Dietary Bioactive Lipids in Neuroinflammatory Diseases 165
Activity-based protein profiling reveals off-target proteins of the FAAH inhibitor BIA 10-2474 162
Platelet activation: a new vascular activity of anandamide [2] 139
Cannabinoid CB2 receptor ligand profiling reveals biased signalling and off-target activity 136
Advances in the discovery of fatty acid amide hydrolase inhibitors: what does the future hold? 127
Characterization of Endocannabinoid System and Interleukin Profiles in Ovine AEC: Cannabinoid Receptors Type-1 and Type-2 as Key Effectors of Pro-Inflammatory Response 115
Development of novel multipotent compounds modulating endocannabinoid and dopaminergic systems 113
The endocannabinoid hydrolase FAAH is an allosteric enzyme 108
Assay of NAPE-PLD Activity 105
The novel, orally available and peripherally restricted selective cannabinoid CB2 receptor agonist LEI-101 prevents cisplatin-induced nephrotoxicity 97
Lipid Discovery by Combinatorial Screening and Untargeted LC-MS/MS 83
Palmitoylation of cysteine 415 of CB1 receptor affects ligand-stimulated internalization and selective interaction with membrane cholesterol and caveolin 1 82
Plant-Derived and Endogenous Cannabinoids in Epilepsy 76
Bisphenol a deranges the endocannabinoid system of primary sertoli cells with an impact on inhibin b production 47
Biochimica del sangue 45
Endomorphin-1 prevents lipid accumulation via CD36 down-regulation and modulates cytokines release from human lipid-laden macrophages 42
Dynamic changes of anandamide in the cerebrospinal fluid of Parkinson's disease patients 36
Exploring the 1,3-benzoxazine chemotype for cannabinoid receptor 2 as a promising anti-cancer therapeutic 33
Selective Fatty Acid Amide Hydrolase Inhibitors as Potential Novel Antiepileptic Agents 31
Computational and Experimental Drug Repurposing of FDA-Approved Compounds Targeting the Cannabinoid Receptor CB1 20
Chemical proteomics reveals off-targets of the anandamide reuptake inhibitor WOBE437 19
Endocannabinoids and platelets - Signalling pathways 17
Endocannabinoids and platelets - Differentiation 17
In silico and in vitro analysis of major cannabis-derived compounds as fatty acid amide hydrolase inhibitors 16
Radiometric Assay of NAPE-PLD Activity 15
Effects of Long-Term Oral Administration of N-Palmitoylethanolamine in Subjects with Mild Cognitive Impairment: Study Protocol 14
Conformational Dynamics of Lipoxygenases and Their Interaction with Biological Membranes 14
DNA-Protein-Interaction (DPI)-ELISA Assay for PPAR-γ Receptor Binding 13
RG7774 (Vicasinabin), an orally bioavailable cannabinoid receptor 2 (CB2R) agonist, decreases retinal vascular permeability, leukocyte adhesion, and ocular inflammation in animal models 4
Totale 23.420
Salva come PNG Salva come JPEG
Categoria #
all - tutte 47.666
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 47.666
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20204.283 0 0 0 0 469 634 524 578 612 514 479 473
2020/20213.671 419 464 416 459 374 355 443 367 81 91 145 57
2021/2022824 19 91 38 43 19 71 37 33 54 110 82 227
2022/2023981 110 85 20 128 75 238 75 61 93 5 69 22
2023/2024318 30 11 15 15 27 87 8 23 2 3 38 59
2024/2025826 88 414 183 106 35 0 0 0 0 0 0 0
Totale 23.420